Recent News

• 08.05.2026 - Moelis Continues Expansion of Private Capital Advisory Business with Appointment of Rich Saltzman
• 07.29.2026 - Moelis & Company Reports Second Quarter and First Half 2026 Financial Results
• 07.22.2026 - Moelis Expands Capital Markets Capabilities with Hire of Megan Dwyer Agar, Establishing Securitization and Structured Products Capability
• 07.15.2026 - Moelis Hires Justin Polselli as a Managing Director in Capital Markets
• 07.08.2026 - Moelis & Company to Announce Second Quarter 2026 Financial Results and Host a Conference Call on July 29, 2026
• 06.15.2026 - Moelis Appoints James McEwan as a Managing Director in Mergers & Acquisitions
• 06.03.2026 - Moelis CEO Navid Mahmoodzadegan to Speak at the 2026 Morgan Stanley US Financials Conference
• 06.03.2026 - Moelis Relocates London Office to Marylebone
• 05.19.2026 - Moelis Expands its Global Chemicals Franchise with Appointment of Matt Knott as a Managing Director in London
• 04.29.2026 - Moelis & Company Reports First Quarter 2026 Financial Results

Recent Filings

• 08.04.2026 - 144 Report of proposed sale of securities
• 07.30.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.29.2026 - 8-K Current report
• 07.29.2026 - EX-99.1 EX-99.1
• 07.16.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 07.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 07.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 07.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.26.2026 - 8-K Current report